申请人:Phan Trung Hieu
公开号:US20050124581A1
公开(公告)日:2005-06-09
The present invention relates to novel α-substituted heteroarylalkylphosphonate derivatives and their uses for lowering plasma levels of apo (a), Lp(a), apo B, apo B associated lipoproteins (low density lipoproteins and very low density lipoproteins) and for lowering plasma levels of total cholesterol.
本发明涉及新型的α-取代杂环烷基膦酸酯衍生物及其用于降低血浆apo(a)、Lp(a)、apo B、apo B相关脂蛋白(低密度脂蛋白和超低密度脂蛋白)和降低总胆固醇血浆水平的用途。